Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Allergy Therapeutics Plc (AGY.LN)

Allergy Therapeutics Plc (AGY.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 133,460
  • Shares Outstanding, K 4,766,440
  • Annual Sales, $ 59,587 K
  • Annual Income, $ -43,071 K
  • 60-Month Beta N/A
  • Price/Sales 0.91
  • Price/Cash Flow N/A
  • Price/Book 5.04
Trade AGY.LN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.06
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.500 +12.00%
on 03/26/24
3.200 -12.50%
on 04/03/24
+0.050 (+1.82%)
since 03/25/24
3-Month
1.800 +55.56%
on 01/31/24
3.200 -12.50%
on 04/03/24
+0.300 (+12.00%)
since 01/02/24

Most Recent Stories

More News
Allergy Therapeutics announces FDA clearance of IND application for novel peanut allergy vaccine candidate VLP Peanut

Allergy Therapeutics plc(“Allergy Therapeutics”, “ATL” or the “Group”) Allergy Therapeutics announces FDA clearance of IND application for novel peanut...

AGY.LN : 2.800 (-1.75%)

Key Turning Points

3rd Resistance Point 3.000
2nd Resistance Point 2.950
1st Resistance Point 2.900
Last Price 2.800
1st Support Level 2.800
2nd Support Level 2.750
3rd Support Level 2.700

See More

52-Week High 3.900
Last Price 2.800
Fibonacci 61.8% 2.716
Fibonacci 50% 2.350
Fibonacci 38.2% 1.984
52-Week Low 0.800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar